Demographic and clinical data for a cohort of liver transplant recipients who developed AKI after transplant surgery.
Sex | |
Male | 56% |
Female | 44% |
Age (years) | 53.5 ± 11.3 |
Race | |
Caucasian | 85% |
African | 3% |
Hispanic | 9% |
Asian | 3% |
Body mass index (kg/m2) | 27.5 ± 5.03 |
Presurgery plasma 8OHdG (ng/ml) | 11.8 ± 8.14 |
Postsurgery plasma 8OHdG (ng/ml) | 16.3 ± 11.8 |
Presurgery plasma THP (ng/ml) | 291 ± 258 |
Postsurgery plasma THP (ng/ml) | 102 ± 93.6 |
Presurgery eGFR (ml/min per 1.73 m2) | 67.8 ± 33.0 |
Presurgery plasma creatinine (mg/dl) | 1.32 ± 0.807 |
Postsurgery plasma creatinine (mg/dl) | 1.53 ± 0.689 |
AKI stage | |
Stage 1 | 15% |
Stage 2 | 29% |
Stage 3 | 56% |
Received dialysis | 47% |
Sixty-day survival | 77% |